Thomas Eldridge Stinchcombe (Tom Stinchcombe, Thomas E Stinchcombe)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Giordano Fabricio Cittolin-Santos, Brendan Knapp, Bharath Ganesh, Feng Gao, Saiama Waqar, Thomas Eldridge Stinchcombe, Ramaswamy Govindan, Daniel Morgensztern
The changing landscape of small cell lung cancer. Cancer 130 (14) (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Giordano Fabricio Cittolin-Santos, Brendan Knapp, Bharath Ganesh, Feng Gao, Saiama Waqar, Thomas Eldridge Stinchcombe, Ramaswamy Govindan, Daniel Morgensztern
The changing landscape of small cell lung cancer. Cancer (2024)
Robert G Maki, Thomas Eldridge Stinchcombe, Gary K Schwartz, Gini F Fleming, Alexia E Iasonos
Combining Response and Toxicity Data to Implement Project Optimus. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Giordano Fabricio Cittolin-Santos, Brendan Knapp, Bharath Ganesh, Feng Gao, Saiama Waqar, Thomas Eldridge Stinchcombe, Ramaswamy Govindan, Daniel Morgensztern
The changing landscape of small cell lung cancer. Cancer 130 (14) (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Thomas Eldridge Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de Perrot, John D Mitchell, Robert Keenan, Thomas Bauer, Daniel Miller, Nasser Altorki
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Siqi Zhang, Jianrong Zhang, Sida Liu, Herbert H Pang, Thomas Eldridge Stinchcombe, Xiaofei Wang
Enrollment Success, Factors, and Prediction Models in Cancer Trials (2008-2019). JCO oncology practice (2023)
Thomas Eldridge Stinchcombe
Flashback Foreword: Pemetrexed and Cisplatin in Mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (12) (2023)
Jeffrey A Bogart, Xiaofei Wang, Gregory A Masters, Junheng Gao, Ritsuko Komaki, Laurie E Gaspar, John Victor Heymach, James Bonner, Charles Kuzma, Saiama Waqar, William Petty, Thomas Eldridge Stinchcombe, Jeffrey D Bradley, Everett E Vokes
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thomas Eldridge Stinchcombe
Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLC. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (13) (2023)
Thomas Eldridge Stinchcombe
Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (6) (2023)
Thomas Eldridge Stinchcombe
Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (15) (2023)
Thomas Eldridge Stinchcombe
Flashback Foreword: Cisplatin/Pemetrexed in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (14) (2023)
Jeffrey A Bogart, Xiaofei Wang, Gregory A Masters, Junheng Gao, Ritsuko Komaki, Laurie E Gaspar, John Victor Heymach, James Bonner, Charles Kuzma, Saiama Waqar, William Petty, Thomas Eldridge Stinchcombe, Jeffrey D Bradley, Everett E Vokes
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jeffrey A Bogart, Xiaofei Wang, Gregory A Masters, Junheng Gao, Ritsuko Komaki, Laurie E Gaspar, John Victor Heymach, James Bonner, Charles Kuzma, Saiama Waqar, William Petty, Thomas Eldridge Stinchcombe, Jeffrey D Bradley, Everett E Vokes
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thomas Eldridge Stinchcombe
Encorafenib and Binimetinib: A New Treatment Option for BRAF V600E -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thomas Eldridge Stinchcombe
Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (16) (2023)
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, Jean-Luc Canon, Matthew D Galsky, Erika Paige Hamilton, Hidetoshi Hayashi, Guy Jerusalem, Seung Tae Kim, Keun-Wook Lee, Lionel Aurelien Kankeu Fonkoua, Bradley J Monk, Danny Nguyen, Do Youn Oh, Alicia F C Okines, David M O'Malley, Paula Pohlmann, Martin Reck, Sang Joon Shin, Kazuki Sudo, Shunji Takahashi, Cedric Van Marcke, Evan Y Yu, Roman Groisberg, Jorge Ramos, Sherry Tan, Thomas Eldridge Stinchcombe, Tanios S Bekaii-Saab
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thomas Eldridge Stinchcombe, Jeffrey D Bradley
Thoracic Oncology: Current Standard Therapy and Future Developments. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (6) (2022)
Suresh R Ramalingam, Eddie Thara, Mark M Awad, Afshin Dowlati, Basir Haque, Thomas Eldridge Stinchcombe, Grace K Dy, David R Spigel, Sharon Lu, Nithya Iyer Singh, Yongqiang Tang, Iryna Teslenko, Nicholas Iannotti
JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer. Cancer (2021)
Jared M Weiss, Nathan Pennell, Allison M Deal, Daniel Morgensztern, Daniel S Bradford, Jeffrey Crane, Howard Jack West, Carrie Lee, Chad Pecot, James P Stevenson, William Irvin, Mark Socinski, Thomas Eldridge Stinchcombe, Liza C Villaruz, Hyman B Muss
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy. Cancer 126 (5) (2020)